a 65 years old male presented with abdominal pain (r.u.q) and constipation, associated with weight loss and anorexia since 40 days prior to admission. serum biochemical tests were normal. colonoscopy showed hemorrhagic polypoid lesion in the cecum. barium enema revealed filling defect in the cecum. sonography revealed a target-shaped lesion (3cm×2.5cm) in upper segment of the right hepatic lobe...

In December 2001, a 49-year-old man presented for evaluation of a gallstone. Abdominal contrast-enhanced computed tomography (CT) incidentally revealed a heteroge-nous mass measuring 36 mm in diameter in the left adrenal lesion, which was suspected of being pheochromocytoma (Picture 1A, arrow). Serum adrenaline, noradrenaline,

UNLABELLED The aims of this study were to examine the relationship between whole-body absorbed dose and hematologic toxicity and to assess the most accurate method of delivering a prescribed whole-body absorbed dose in (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy for neuroblastoma. METHODS A total of 20 children (1-12 y), 5 adolescents (13-17 y), and 1 adult (20 y) with stage 3 or 4 n...

BACKGROUND (131)I Metaiodobenzylguanidine ((131)I-MIBG) is an effective targeted radiotherapeutic for neuroblastoma with response rates greater than 30% in refractory disease. Toxicity is mainly limited to myelosuppression. The aim of this study was to determine the response rate and hematologic toxicity of multiple infusions of (131)I-MIBG. PROCEDURE Patients received two to four infusions o...

Neuroblastoma is unique amongst common pediatric cancers for its expression of the norepinephrine transporter (NET), enabling tumor-selective imaging and therapy with radioactive analogues of norepinephrine. The majority of neuroblastoma tumors are avid for (123)I-metaiodobenzaguanidine (mIBG) on imaging, yet the therapeutic response to (131) I-mIBG is only 30% in clinical trials, and off-targe...

UNLABELLED In this investigation, the efficacy of scintigraphy using (99m)Tc-labeled hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) in the evaluation of extraadrenal pheochromocytoma was assessed and compared with (131)I-labeled metaiodobenzylguanidine (MIBG) imaging. METHODS Ninety-seven patients who were suspected of having pheochromocytoma but showed no definite adrenal abnormalities on CT...